EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Diagnos's enterprise value is C$27.78 Mil.
Diagnos's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 was C$0.20 Mil. Therefore, Diagnos's EV-to-Revenue for today is 141.74.
The historical rank and industry rank for Diagnos's EV-to-Revenue or its related term are showing as below:
TSXV:ADK'
s EV-to-Revenue Range Over the Past 10 Years
Min: 1.62 Med: 16.3 Max: 171.12
Current: 141.74
During the past 13 years, the highest EV-to-Revenue of Diagnos was 171.12. The lowest was 1.62. And the median was 16.30.
TSXV:ADK's EV-to-Revenue is ranked worse than 98.04% of 663
companies
in the Healthcare Providers & Services industry
Industry Median: 1.86
vs TSXV:ADK: 141.74
As of today (2024-05-28), Diagnos's stock price is C$0.32.
Diagnos's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 was C$0.00. Therefore, Diagnos's PS Ratio for today is 106.67.
Diagnos EV-to-Revenue Historical Data
The historical data trend for Diagnos's EV-to-Revenue can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Health Information Services subindustry, Diagnos's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Diagnos's EV-to-Revenue Distribution in the Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Diagnos's EV-to-Revenue distribution charts can be found below:
* The bar in red indicates where Diagnos's EV-to-Revenue falls into.
Diagnos's current Enterprise Value is C$27.78 Mil.
Diagnos's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was C$0.20 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Diagnos's share price for today is C$0.32.
Diagnos's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was C$0.00.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Diagnos EV-to-Revenue Related Terms
Thank you for viewing the detailed overview of Diagnos's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.
Diagnos Inc is engaged in the provision of software-based interpretation services to assist health specialists in the detection of diabetic retinopathy. The company provides image analysis services through CARA (Computer Assisted Retinal Analysis). It operates in the business segment of Healthcare services. The company has a business presence in Canada, the United States, UAE, Saudi Arabia, Mexico, Costa Rica, and others. The company's key revenue is derived from Canada.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
TSXV:ADK has been successfully added to your 